Jennifer N. Brudno

T Cells Genetically Modified to Express an Anti–B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple Myeloma

Jennifer N. Brudno, Irina Marić, Steven D. Hartman et al. · Journal of Clinical Oncology · 2018 · 791 citations · Full text

Medicine, Hematology, Immunology +15

T cells expressing an anti–B-cell maturation antigen chimeric antigen receptor cause remissions of multiple myeloma

Syed Abbas Ali, Victoria Shi, Irina Marić et al. · Blood · 2016 · 766 citations · Full text

Life Sciences, Immunology, Oncology +14

Allogeneic T Cells That Express an Anti-CD19 Chimeric Antigen Receptor Induce Remissions of B-Cell Malignancies That Progress After Allogeneic Hematopoietic Stem-Cell Transplantation Without Causing Graft-Versus-Host Disease

Jennifer N. Brudno, Robert Somerville, Victoria Shi et al. · Journal of Clinical Oncology · 2016 · 609 citations · Full text

Life Sciences, Hematology, Immunology +13

Safety and feasibility of anti-CD19 CAR T cells with fully human binding domains in patients with B-cell lymphoma

Jennifer N. Brudno, Norris Lam, Danielle Vanasse et al. · Nature Medicine · 2020 · 314 citations · Full text

Life Sciences, Hematology, Immunology +12

Society for Immunotherapy of Cancer (SITC) clinical practice guideline on immune effector cell-related adverse events

Marcela V. Maus, S. Alexander, Michael R. Bishop et al. · Journal for ImmunoTherapy of Cancer · 2020 · 269 citations · Full text

Life Sciences, Immunology, Oncology +17